{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T10:11:16Z","timestamp":1774260676437,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T00:00:00Z","timestamp":1769299200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10157-026-02819-8","type":"journal-article","created":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T01:42:00Z","timestamp":1769305320000},"page":"643-651","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term outcomes of initial tonsillectomy and steroid pulse therapy in children with IgA nephropathy and heavy proteinuria: a single-center retrospective study"],"prefix":"10.1007","volume":"30","author":[{"given":"Nozomi","family":"Nomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-3705","authenticated-orcid":false,"given":"Shuichiro","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Miyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayu","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Sakuraya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amane","family":"Endo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,25]]},"reference":[{"key":"2819_CR1","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/S0140-6736(98)03563-6","volume":"353","author":"C Pozzi","year":"1999","unstructured":"Pozzi C, Bolasco PG, Fogazzi GB, Andrulli S, Altieri P, Ponticelli C, et al. Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet. 1999;353:883\u20137.","journal-title":"Lancet"},{"key":"2819_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/01.ASN.0000103869.08096.4F","volume":"15","author":"C Pozzi","year":"2004","unstructured":"Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, et al. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial. J Am Soc Nephrol. 2004;15:157\u201363.","journal-title":"J Am Soc Nephrol"},{"key":"2819_CR3","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1093\/ndt\/gfu020","volume":"29","author":"T Kawamura","year":"2014","unstructured":"Kawamura T, Yoshimura M, Miyazaki Y, Okamoto H, Kimura K, Hirano K, et al. A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy. Nephrol Dial Transplant. 2014;29:1546\u201353.","journal-title":"Nephrol Dial Transplant"},{"key":"2819_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","volume":"100","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases. Kidney Int. 2021;100:S1\u2013276.","journal-title":"Kidney Int"},{"key":"2819_CR5","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1007\/s10157-021-02095-8","volume":"25","author":"H Suzuki","year":"2021","unstructured":"Suzuki H, Kikuchi M, Koike K, Komatsu H, Matsuzaki K, Takahashi K, et al. A digest from evidence-based clinical practice guideline for IgA nephropathy 2020. Clin Exp Nephrol. 2021;25:1269\u201376.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR6","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1007\/s10157-023-02396-0","volume":"27","author":"K Matsuzaki","year":"2023","unstructured":"Matsuzaki K, Suzuki H, Kikuchi M, Koike K, Komatsu H, Takahashi K, et al. Current treatment status of IgA nephropathy in Japan: a questionnaire survey. Clin Exp Nephrol. 2023;27:1032\u201341.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR7","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1007\/s00467-024-06361-1","volume":"39","author":"B Su","year":"2024","unstructured":"Su B, Jiang Y, Li Z, Zhou J, Rong L, Feng S, et al. Are children with IgA nephropathy different from adult patients? Pediatr Nephrol. 2024;39:2403\u201312.","journal-title":"Pediatr Nephrol"},{"key":"2819_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s10157-018-1553-7","volume":"22","author":"A Yamada","year":"2018","unstructured":"Yamada A, Fujinaga S, Sakuraya K, Satoshi A, Hirano D. Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy. Clin Exp Nephrol. 2018;22:1143\u20139.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10157-020-01877-w","volume":"24","author":"S Fujinaga","year":"2020","unstructured":"Fujinaga S, Umeda C. Risk factor for persistent proteinuria in adulthood after clinical remission in Japanese children with immunoglobulin A nephropathy: impact of tonsillectomy combined with intravenous pulse methylprednisolone. Clin Exp Nephrol. 2020;24:734\u20135.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR10","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, et al. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR11","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","volume":"91","author":"H Trimarchi","year":"2017","unstructured":"Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA nephropathy classification working group. Kidney Int. 2017;91:1014\u201321.","journal-title":"Kidney Int"},{"key":"2819_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27\u201338.","journal-title":"Biometrika"},{"key":"2819_CR13","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1002\/sim.1047","volume":"21","author":"G Heinze","year":"2002","unstructured":"Heinze G, Schemper M. A solution to the problem of separation in logistic regression. Stat Med. 2002;21:2409\u201319.","journal-title":"Stat Med"},{"key":"2819_CR14","doi-asserted-by":"publisher","first-page":"511","DOI":"10.2215\/CJN.01120905","volume":"1","author":"N Yoshikawa","year":"2006","unstructured":"Yoshikawa N, Honda M, Iijima K, Awazu M, Hattori S, Nakanishi K, et al. Steroid treatment for severe childhood IgA nephropathy: a randomized, controlled trial. Clin J Am Soc Nephrol. 2006;1:511\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2819_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1681\/ASN.V101101","volume":"10","author":"N Yoshikawa","year":"1999","unstructured":"Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, et al. A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. J Am Soc Nephrol. 1999;10:101\u20139.","journal-title":"J Am Soc Nephrol"},{"key":"2819_CR16","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.2215\/CJN.08630910","volume":"6","author":"K Kamei","year":"2011","unstructured":"Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, et al. Long-term results of a randomized controlled trial in childhood IgA nephropathy. Clin J Am Soc Nephrol. 2011;6:1301\u20137.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2819_CR17","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s10157-016-1231-6","volume":"20","author":"M Hattori","year":"2016","unstructured":"Hattori M, Iwano M, Sako M, Honda M, Okada H, Akioka Y, et al. Transition of adolescent and young adult patients with childhood-onset chronic kidney disease from pediatric to adult renal services: a nationwide survey in Japan. Clin Exp Nephrol. 2016;20:918\u201325.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR18","first-page":"51","volume":"61","author":"K Miura","year":"2019","unstructured":"Miura K. A questionnaire survey of recognition and utilization of clinical guideline for IgA nephropathy and minimal change nephrotic syndrome. Nihon Jinzo Gakkai Shi. 2019;61:51\u20137.","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"2819_CR19","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10157-013-0779-7","volume":"17","author":"K Matsuzaki","year":"2013","unstructured":"Matsuzaki K, Suzuki Y, Nakata J, Sakamoto N, Horikoshi S, Kawamura T, et al. Nationwide survey on current treatments for IgA nephropathy in Japan. Clin Exp Nephrol. 2013;17:827\u201333.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1007\/s00467-023-06259-4","volume":"39","author":"L Antonucci","year":"2024","unstructured":"Antonucci L, Fuiano L, Gargiulo A, Gianviti A, Onetti Muda A, Diomedi Camassei F, et al. Childhood-onset IgA nephropathy: is long-term recovery possible? Pediatr Nephrol. 2024;39:1837\u201346.","journal-title":"Pediatr Nephrol"},{"key":"2819_CR21","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s00467-023-06203-6","volume":"39","author":"S Fujinaga","year":"2024","unstructured":"Fujinaga S, Saito K. Initial treatment with tonsillectomy combined with intravenous methylprednisolone pulse - another option for Japanese children with severe nephrotic IgA vasculitis with nephritis. Pediatr Nephrol. 2024;39:1671\u20132.","journal-title":"Pediatr Nephrol"},{"key":"2819_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00467-024-06502-6","volume":"40","author":"M Vivarelli","year":"2025","unstructured":"Vivarelli M, Samuel S, Coppo R, Barratt J, Bonilla-Felix M, Haffner D, et al. IPNA clinical practice recommendations for the diagnosis and management of children with IgA nephropathy and IgA vasculitis nephritis. Pediatr Nephrol. 2025;40:533\u201369.","journal-title":"Pediatr Nephrol"},{"key":"2819_CR23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.4772","volume":"2","author":"K Hirano","year":"2019","unstructured":"Hirano K, Matsuzaki K, Yasuda T, Nishikawa M, Yasuda Y, Koike K, et al. Association between tonsillectomy and outcomes in patients with Immunoglobulin A nephropathy. JAMA Netw Open. 2019;2:e194772.","journal-title":"JAMA Netw Open"},{"key":"2819_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5414\/CN107861","volume":"80","author":"M Ohya","year":"2013","unstructured":"Ohya M, Otani H, Minami Y, Yamanaka S, Mima T, Negi S, et al. Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. Clin Nephrol. 2013;80:47\u201352.","journal-title":"Clin Nephrol"},{"key":"2819_CR25","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10157-015-1170-7","volume":"20","author":"K Hirano","year":"2016","unstructured":"Hirano K, Amano H, Kawamura T, Watanabe K, Koike K, Shimizu A, et al. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification. Clin Exp Nephrol. 2016;20:425\u201332.","journal-title":"Clin Exp Nephrol"},{"key":"2819_CR26","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/0886022X.2015.1128251","volume":"38","author":"D Yang","year":"2016","unstructured":"Yang D, He L, Peng X, Liu H, Peng Y, Yuan S, et al. The efficacy of tonsillectomy on clinical remission and relapse in patients with IgA nephropathy: a randomized controlled trial. Ren Fail. 2016;38:242\u20138.","journal-title":"Ren Fail"},{"key":"2819_CR27","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1620\/tjem.250.61","volume":"250","author":"C Umeda","year":"2020","unstructured":"Umeda C, Fujinaga S, Endo A, Sakuraya K, Asanuma S, Hirano D. Preventive effect of tonsillectomy on recurrence of Henoch-Sch\u00f6nlein purpura nephritis after intravenous methylprednisolone pulse therapy. Tohoku J Exp Med. 2020;250:61\u20139.","journal-title":"Tohoku J Exp Med"},{"key":"2819_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1111\/ped.14264","volume":"62","author":"T Enya","year":"2020","unstructured":"Enya T, Miyazaki K, Miyazawa T, Oshima R, Morimoto Y, Okada M, et al. Early tonsillectomy for severe immunoglobulin A nephropathy significantly reduces proteinuria. Pediatr Int. 2020;62:1054\u20137.","journal-title":"Pediatr Int"},{"key":"2819_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ped.13074","volume":"59","author":"Y Kawasaki","year":"2017","unstructured":"Kawasaki Y, Maeda R, Kanno S, Suzuki Y, Ohara S, Suyama K, et al. Long-term follow up of pediatric immunoglobulin A nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy. Pediatr Int. 2017;59:41\u20137.","journal-title":"Pediatr Int"},{"key":"2819_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02068","volume":"11","author":"M Kawabe","year":"2020","unstructured":"Kawabe M, Yamamoto I, Yamakawa T, Katsumata H, Isaka N, Katsuma A, et al. Association between galactose-deficient IgA1 derived from the tonsils and recurrence of IgA nephropathy in patients who underwent kidney transplantation. Front Immunol. 2020;11:2068.","journal-title":"Front Immunol"},{"key":"2819_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5387\/fms.2022-42","volume":"69","author":"Y Kawasaki","year":"2023","unstructured":"Kawasaki Y, Kume Y, Ono A, Maeda R, Go H. Differences in response to treatment in children with severe IgA nephropathy according to patient age. Fukushima J Med Sci. 2023;69:125\u201332.","journal-title":"Fukushima J Med Sci"},{"key":"2819_CR32","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00467-014-3019-9","volume":"30","author":"K Kamei","year":"2015","unstructured":"Kamei K, Nakanishi K, Ito S, Ishikura K, Hataya H, Honda M, et al. Risk factors for persistent proteinuria after a 2-year combination therapy for severe childhood IgA nephropathy. Pediatr Nephrol. 2015;30:961\u20137.","journal-title":"Pediatr Nephrol"},{"key":"2819_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s10157-015-1153-8","volume":"20","author":"M Tanaka","year":"2016","unstructured":"Tanaka M, Miyazaki Y, Koike K, Ueda H, Tsuboi N, Hirano K, et al. Clinicopathological characteristics of patients with immunoglobulin A nephropathy showing acute exacerbations after favorable long-term clinical courses. Clin Exp Nephrol. 2016;20:226\u201334.","journal-title":"Clin Exp Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10157-026-02819-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-026-02819-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T09:28:24Z","timestamp":1774258104000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10157-026-02819-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,25]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["2819"],"URL":"https:\/\/doi.org\/10.1007\/s10157-026-02819-8","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,25]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects of the Ministry of Health, Labour and Welfare of Japan. This study was approved by the Ethics Committee of Saitama Children\u2019s Medical Center (approval no. 2021\u201306-004).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The Institutional Review Board waived the requirement for informed consent due to the retrospective nature of this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The present study complies with the guidelines for human studies. This study does not contain any studies with animals.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}}]}}